CSG NV said it expects sales to top last year’s record as heightened geopolitical tensions spur demand for ammunitions and armaments. Revenue may climb to as much as €7.6 billion ($8.8 billion) in 2026 after surging 72% to €6.74 billion last year, the company said Thursday, in its first earnings release since going public in January. CSG said it has a €15 billion backlog, an indication of continui...
CSG NV said it expects sales to top last year’s record as heightened geopolitical tensions spur demand for ammunitions and armaments. Revenue may climb to as much as €7.6 billion ($8.8 billion) in 2026 after surging 72% to €6.74 billion last year, the company said Thursday, in its first earnings release since going public in January. CSG said it has a €15 billion backlog, an indication of continuing demand. “We are well placed to capitalize on a strong demand environment driven by near-term geopolitical developments, multiyear procurement frameworks and structural defense budget increases across NATO and allied nations,” Chief Executive Officer Michal Strnad said in a statement. Read More: Europe’s Carmaking Powerhouse Wants to Become Its Ammunition Hub Once deeply unfashionable, the defense sector is booming as fraying geopolitical ties boosts military spending. CSG has secured a string of large contracts in recent months including the delivery of military trucks to an unidentified customer in Asia and the production of hulls for Leopard 2A8 tanks in cooperation with KNDS. CSG has seen the biggest demand for weapons since the end of the Cold War after Russia sent troops to Ukraine four years ago. The company is one of the key suppliers of munitions and armored vehicles to Ukraine. Rising demand for armaments underpinned CSG’s IPO in Amsterdam earlier this year, which saw Strnad’s net worth roughly double to about $31.9 billion and made him the richest Czech person, according to the Bloomberg Billionaires Index .
OptimizeRx (OPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OptimizeRx (OPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
(RTTNews) - Delivery Hero SE (DELHY, DHER.DE), a German online food ordering and delivery platform, reported Thursday narrower net loss in fiscal 2025 with higher revenues and slight growth in Gross Merchandise Value or GMV. The company also provided its outlook for fiscal year 2
(RTTNews) - Delivery Hero SE (DELHY, DHER.DE), a German online food ordering and delivery platform, reported Thursday narrower net loss in fiscal 2025 with higher revenues and slight growth in Gross Merchandise Value or GMV. The company also provided its outlook for fiscal year 2
Photo: IC photo Chinese monetary authorities have verbally instructed some banks to limit trading with their own funds in bonds traded on exchanges to the centralized trading system, Caixin learned from people familiar with the matter. Authorities in Jiangsu province have directed several local small and midsize banks to restrict their use of the fixed-income trading platform in bond trading activ...
Photo: IC photo Chinese monetary authorities have verbally instructed some banks to limit trading with their own funds in bonds traded on exchanges to the centralized trading system, Caixin learned from people familiar with the matter. Authorities in Jiangsu province have directed several local small and midsize banks to restrict their use of the fixed-income trading platform in bond trading activities, they told Caixin Thursday.